Effect Of Multiple Biofortified Food Crops On Micronutrient Status And Immune Function Among Indian Infants and Their Mothers
NCT ID: NCT02648893
Last Updated: 2023-05-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2019-02-28
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Iron/Zinc-Biofortified Pearl Millet on Growth and Immunity in Children Aged 12-18 Months in India
NCT02233764
Using Iodized Salt to Improve Serum Folate, B12 and Iron Levels
NCT06904612
Feeding Trial of Bio-fortified Pearl Millet
NCT02152150
Effect of Regular Consumption of Micronutrient Fortified Beverage on the Micronutrient Status of Indian Schoolchildren
NCT01415557
Study of Multiply-fortified Salt Among Women of Reproductive Age and Preschool Children in India
NCT05166980
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MBFC-Exp
The MBFC-Exp (Multiple biofortified food crops - Experimental) arm will consume meals based on biofortified food crops.
Multiple biofortified food crops (MBFC-Exp)
Meals from three biofortified food crops will be consumed by children (and potentially their lactating mothers) three times per day, six days per week, for 9 months.
MBFC-C
The MBFC-C (Multiple biofortified food crops - Control) arm will consume the same meals based on non-biofortified (commercially available) food crops.
Commercially available non-fortified food crops (MBFC-C)
This arm will consume meals based on three commercially available (non-biofortified) food crops three times per day, six days per week, for 9 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multiple biofortified food crops (MBFC-Exp)
Meals from three biofortified food crops will be consumed by children (and potentially their lactating mothers) three times per day, six days per week, for 9 months.
Commercially available non-fortified food crops (MBFC-C)
This arm will consume meals based on three commercially available (non-biofortified) food crops three times per day, six days per week, for 9 months.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Mothers: Biological mothers of included children.
Exclusion Criteria
* Age below 6 months or above 24 months (at time of screening);
* Hemoglobin \<9 g/dL (at time of screening);
* Presence of severe malnutrition according to Wellcome Classification (marasmus, marasmic kwashiorkor, kwashiorkor, weight-for-height z-score \< -3);
* Prior known or current diagnoses of HIV/AIDS, Malaria, Dengue fever, Tuberculosis;
* Children whose biological mother is unable to bring her/him to feeding center daily;
* Possibility of migrating out of the study catchment area for more than 4 consecutive weeks;
* Prior or current consumption of iron, zinc, and/or vitamin A supplements;
* Any known dietary allergies.
Mothers
\- Severe anemia (Hemoglobin \<7g/ dL)
6 Months
24 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SNDT Women's University
OTHER
Arogyavaram Medical Centre
OTHER
Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Saurabh Mehta, MBBS, ScD
Role: PRINCIPAL_INVESTIGATOR
Cornell University
Julia L. Finkelstein, ScD
Role: PRINCIPAL_INVESTIGATOR
Cornell University
Shobha Udipi, PhD
Role: PRINCIPAL_INVESTIGATOR
SNDT Women's University
Bonam Wesley, MBBS
Role: PRINCIPAL_INVESTIGATOR
Arogyavaram Medical Centre
Jere D Haas, PhD
Role: PRINCIPAL_INVESTIGATOR
Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arogyavaram Medical Centre
Madanapalle, , India
S.N.D.T. Women's University
Mumbai, , India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB #: 1508005782
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.